What the research firmly supports: BPC-157's gut healing, vascular, and neuroprotective mechanisms (strong preclinical evidence) Thymosin Alpha-1's immune modulating and T-cell restorative effects (strong preclinical + clinical evidence in viral disease) TB-500's cardiovascular repair and angiogenic properties (strong preclinical, early human data) What the research does not yet confirm: Randomised controlled trial data specifically in long COVID populations Optimal dosing, sequencing, and duration specifically for PASC Long-term safety data for extended post-viral use This doesn't mean these peptides don't work for long COVID
These injections are much more than your standard B12 injection and have many other benefits
ProHealth includes BPC-157 as a research-grade dietary ingredient for adults interested in supporting their general wellness.* The Science of Resilience- What Preclinical Research has Explored Animal model studies have investigated BPC-157 in connection with markers related to normal blood flow support, cellular maintenance, and a balanced inflammatory response within normal ranges.* Experimental cell and animal studies have also examined BPC-157 models related to: Normal muscle maintenance following physical activity* 1,3,10 Normal circulatory support for tissue nourishment* 2,4,6 Important: All cited research reflects preclinical findings from animal and cell studies
Weeks 3-6: Early Fat Loss Phase Between weeks three and six, the cumulative effect of enhanced daily fat oxidation begins manifesting as measurable changes
